Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy

Clinical Outcomes in Patients with Ischemic versus Non-Ischemic Cardiomyopathy after Angiotensin-Neprilysin Inhibition Therapy

Background: The angiotensin receptor-neprilysin inhibitor (ARNI) decreases cardiovascular mortality in patients with chronic heart failure with a reduced ejection fraction (HFrEF). Data regarding the impact of ARNI on the outcome in HFrEF patients according to heart failure etiology are limited. Met...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohammad Abumayyaleh, Christina Pilsinger, Ibrahim El-Battrawy, Marvin Kummer, Jürgen Kuschyk, Martin Borggrefe, Andreas Mügge, Assem Aweimer, Ibrahim Akin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
ARNI
ICMP
NICMP
sacubitril/valsartan
tachyarrhythmias
outcomes
Medicine
R
Acceso en línea:https://doaj.org/article/8826516588934d4a9a6bdd8986ee1be1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares